135 filings
Page 3 of 7
8-K
byqspbycdh
24 Sep 21
Catalent Announces Upsizing and Pricing of Private Offering of Senior Unsecured Notes Due 2030
12:00am
8-K
roasfytjp
23 Sep 21
Catalent Announces Launch of Private Offering of $450 Million of Senior Unsecured Notes Due 2030
7:54am
8-K
3zm16japvd4hfx6j3j5
30 Aug 21
Catalent, Inc. Reports Fourth Quarter Fiscal 2021 Results
7:15am
8-K
jpctp3w5btirbl
20 May 21
Departure of Directors or Certain Officers
4:33pm
8-K
4nctzzt vmd
11 May 21
Departure of Directors or Certain Officers
7:30am
8-K
9ntaa4xol9o9z
4 May 21
Catalent, Inc. Reports Third Quarter Fiscal 2021 Results
7:07am
8-K
vfsl3ct
22 Feb 21
Entry into a Material Definitive Agreement
4:27pm
8-K
e9g05r susxbd64u
10 Feb 21
Catalent Announces Upsizing and Pricing of Private Offering of Senior Unsecured Notes Due 2029
5:29pm
8-K
trtk46d2m8
10 Feb 21
Catalent Announces Launch of Private Offering of $475 Million of Senior Unsecured Notes Due 2029
7:50am
8-K
oj4ue
2 Feb 21
Catalent, Inc. Reports Second Quarter Fiscal 2021 Results
7:21am
8-K
ahxmbw7urtlhg2crt20
3 Nov 20
Catalent, Inc. Reports First Quarter Fiscal 2021 Results
7:13am
8-K
xqtk1hnca 0boolecrt
31 Aug 20
Catalent, Inc. Reports Fourth Quarter Fiscal 2020 Results
7:06am
8-K
7jf1haq3e sg35u29q5o
30 Jul 20
Results of Operations and Financial Condition
8:22am
8-K
vspgddsspaq0n7
15 Jun 20
Entry into a Material Definitive Agreement
4:20pm
8-K
xty93yj9
11 Jun 20
Catalent, Inc. Announces Pricing of Public Offering of Common Stock
8:52am
8-K
606usney nfb2
10 Jun 20
Catalent, Inc. Announces Public Offering of Common Stock
4:19pm
8-K
n78b72z
5 May 20
Catalent, Inc. Reports Third Quarter Fiscal 2020 Results
7:32am
8-K
cgcp51x gd7
30 Apr 20
Catalent Announces Next Generation of Cell & Gene Therapy Leadership
4:43pm
8-K
jxkexc x6vq
3 Mar 20
Entry into a Material Definitive Agreement
4:16pm
8-K
3jxdv2g6d1bsqaa
20 Feb 20
Catalent Announces Upsizing and Pricing of Private Offering of Senior Unsecured Notes Due 2028
4:28pm